Annual report pursuant to Section 13 and 15(d)

Acquisitions, Investments, and Licenses - Schedule of Bio-Reference Purchase Price Allocation (Details)

v3.6.0.2
Acquisitions, Investments, and Licenses - Schedule of Bio-Reference Purchase Price Allocation (Details) - USD ($)
$ in Thousands
1 Months Ended
Aug. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Business Acquisition [Line Items]        
Goodwill   $ 704,603 $ 743,348 $ 224,292
Bio-Reference Laboratories, Inc.        
Business Acquisition [Line Items]        
Value of OPKO Common Stock issued to Bio-Reference shareholders $ 947,889      
Value of replacement stock options awards to holders of Bio-Reference stock options 2,259      
Total purchase price 950,148      
Cash and cash equivalents 15,800      
Accounts receivable 168,164      
Inventory 19,674      
Other current assets, principally deferred tax assets 105,765      
Total current assets 309,403      
Property, plant and equipment 112,457      
Intangible assets 545,250      
Goodwill 401,821 $ 401,821    
Investments 5,326      
Other assets 13,265      
Total assets 1,387,522      
Accounts payable and accrued expenses (108,217)      
Income taxes payable (2,921)      
Lines of credit and notes payable (65,701)      
Capital lease obligations (18,293)      
Deferred tax liability (non-current) (235,904)      
Other long-term liabilities (6,338)      
Total purchase price 950,148      
Trade names | Bio-Reference Laboratories, Inc.        
Business Acquisition [Line Items]        
Intangible assets 47,100      
Customer relationships | Bio-Reference Laboratories, Inc.        
Business Acquisition [Line Items]        
Intangible assets 389,800      
Technology | Bio-Reference Laboratories, Inc.        
Business Acquisition [Line Items]        
Intangible assets 100,600      
Other intangible assets | Bio-Reference Laboratories, Inc.        
Business Acquisition [Line Items]        
Intangible assets $ 7,750